Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$7.39 -0.12 (-1.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cumberland Pharmaceuticals (CPIX) Return on Sales [ROS] (2010 - 2026)

Updated

Cumberland Pharmaceuticals (CPIX) posted Return on Sales [ROS] of -1898.65% for Q2 2026, down 1079.45 percentage points from -819.21% a year earlier and down 1864.38 percentage points from the prior quarter.

Analysis

Cumberland Pharmaceuticals (CPIX) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Cumberland Pharmaceuticals was -30.79%, down 13.82 percentage points year-over-year; for FY2025, it was -6.27%, up 10.72 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +10.77 percentage points (FY2020 to FY2025).
  • In prior years, Cumberland Pharmaceuticals' Return on Sales [ROS] was -16.99% in FY2024 (+7.17 pp), -24.16% in FY2023 (-10.58 pp), -13.58% in FY2022 (+7.76 pp) and -21.34% in FY2021 (-4.29 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] in data going back to Q2 2010.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -231.21 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2024, with a gain of 48.41 percentage points; the weakest was Q2 2026, with a drop of 1079.45 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -34.27% (Q1 2026), -10.02% (Q4 2025) and -23.70% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Cumberland Pharmaceuticals 112.52 Mn 70.68 Mn - -1,898.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,898.65%
Mar 31, 2026 -34.27%
Dec 31, 2025 -10.02%
Sep 30, 2025 -23.70%
Jun 30, 2025 -819.21%
Mar 31, 2025 11.03%
Dec 31, 2024 -17.65%
Sep 30, 2024 -18.65%
Jun 30, 2024 -10.42%
Mar 31, 2024 -22.00%
Dec 31, 2023 -66.07%
Sep 30, 2023 -18.51%
Jun 30, 2023 0.21%
Mar 31, 2023 -16.60%
Dec 31, 2022 -24.97%
Sep 30, 2022 -2.53%
Jun 30, 2022 -17.93%
Mar 31, 2022 -11.56%
Dec 31, 2021 -52.33%
Sep 30, 2021 -19.37%
API Access

Cumberland Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CPIX&period=max&api_key=YOUR_API_KEY